Dr. Tzu-Hurng Cheng, Ph.D., is a Professor in the Department of Biochemistry, School of Medicine at China Medical University, Taichung, Taiwan. Dr. Cheng’s research focuses on cardiovascular pharmacology with a particular emphasis on understanding molecular mechanisms and developing therapeutic interventions. His dedication to bridging basic research with clinical applications distinguishes his work in advancing treatments for cardiovascular and renal diseases, while his expertise in biochemistry provides a strong foundation for translational research. Dr. Cheng has published over 90 peer-reviewed articles, many as first or corresponding author, in prestigious journals such as Journal of Biomedical Science and European Journal of Pharmacology. His work has been cited extensively, with a Google Scholar H-index of 30. He has delivered over 15 international conference presentations and received awards, including the 18th National Innovation Award for Clinical Innovation. Dr. Cheng has contributed significantly to academic journals, having peer-reviewed more than 80 manuscripts and authored several editorials that advance discussions on innovative approaches in cardiovascular pharmacology. Dr. Cheng aims to explore cutting-edge research in cardiovascular and renal pathophysiology, integrating natural product pharmacology into innovative treatment strategies for chronic diseases. With expertise in leadership, mentoring, and interdisciplinary collaboration, Dr. Cheng excels in fostering research innovation, effective communication, and problem-solving in both academic and clinical settings. Outside of academia, Dr. Cheng enjoys hiking, exploring local cuisines, and participating in cultural events that enrich his perspective on global diversity.